New Lab Testing Results for Recent Dragon Pharma Batches

Nov 11, 2025
British Dragon
Reading Time: 1 min

We're releasing another round of verified, third-party lab test results covering multiple Dragon Pharma batches recently received at our facility. These tests were performed on sealed vials and tablets to confirm accuracy, potency, and consistency before new stock goes into circulation.

Below is the full report:

Peptide Batches – Tested November 2025

Dragon Pharma GHK-CU lab test 2025-11-10 showing 55.10 mg per vial
55.10 mg
Dragon Pharma Ipamorelin/Tesamorelin lab test 2025-11-10 result
5.47 mg/5.33 mg
Dragon Pharma GHRP-6 lab test 2025-11-07 result
2025-11-07
10.38 mg
Dragon Pharma CJC No Dac/Ipamorelin lab test 2025-11-07 result
5.93 mg/4.96 mg
Dragon Pharma GHRP-2 lab test 2025-11-07 result
2025-11-07
5.88 mg

Non-Peptide Products – Tested October 2025

Dragon Pharma Enantat 400 lab test 2025-10-02 showing 418.88 mg/ml
418.88 mg/ml
Dragon Pharma Enclomiphene lab test 2025-10-16 result
25.19 mg/tab
Dragon Pharma SLU-PP-332 lab test 2025-10-16 result
534.91 mcg/tab

These results show consistent overfill across all tested batches, maintaining Dragon Pharma's commitment to transparency and accuracy. More lab data will be published as new results become available.

News

Independent Lab Tests Update – September–October 2025
October 8, 2025 British Dragon
Independent Lab Tests Update – September–October 2025

New independent lab results are in for recent batches from Dragon Pharma and Peptide Hubs (Sept–Oct 2025). Browse test dates and measured content per item and open the certificate images.

Happy New Year 2026 from British Dragon!
January 5, 2026 British Dragon
Happy New Year 2026 from British Dragon!

British Dragon welcomes 2026 with an extended storewide sale. Enjoy major discounts on HGH, select orals, peptides, and Trenbolone Enanthate, plus free shipping on orders over $700. Offers now valid through February 28, 2026.

Patent For Innovative Nanoparticle
Patent For Innovative Nanoparticle

British Dragon Pharma announced today that it has received a U.S. patent relating to its calcium phosphate nanoparticles (CAP). In addition to disclosing the compound itself, the new patent discloses methods of manufacture and use of CAP.

Customer Reviews

Please leave your review on products or service below.
Thank you beforehand.

Write a Review View Reviews

Add to Cart - Product(s)

Close Button
Empty

Total Cost: